HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Third quarter retail sales were up 9.3% to $45.4 mil. and comp store sales rose 6.4% to $40.9 mil., E Com Ventures reports. FY 2005 sales to date are up 7.7% over the prior year to $134.1 mil. During the third quarter, Perfumania store openings increased 2.1%, with the number of U.S. doors now totaling 241. Fragrance retailer unveiled plans this fall to launch private label skin care and cosmetics, as well as a new open-sell store format, in an effort to reach new consumers (1"The Rose Sheet" Sept. 12, 2005, p. 4)...

You may also be interested in...

Perfumania Unveils Private Label Products, Open-Sell Format

Discount fragrance retailer Perfumania is looking to broaden its consumer base with the launch of private label cosmetics and skin care and a new open-sell store format, according to the Sunrise, Fla. company

Regulatory Measures Could Mitigate EU Coronavirus Risks

As part of its response to the coronavirus outbreak, Medicines for Europe has set out a series of policy recommendations that it says could help to mitigate the risks of COVID-19.

EU Off-Patent Industry Sees ‘Limited Immediate Risk’ From COVID-19

 The coronavirus COVID-19 outbreak poses a “limited immediate risk” to European production and supplies of off-patent drugs, according to industry association Medicines for Europe. However, if the situation continues for an extended period an “important impact” cannot be ruled out.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts